Quantcast

Latest Vaccination Stories

2014-10-20 20:25:34

LONDON, Oct. 20, 2014 /PRNewswire/ -- Report DetailsYour guide to trends and revenue prospects for vaccine productionWhat's the outlook for producing vaccines? Visiongain's updated report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for those technologies. Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in the production of vaccines, helping your...

2014-10-16 08:27:40

NEW YORK, Oct. 16, 2014 /PRNewswire/ -- Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines. The healthcare market researcher said that two- to four-year-olds in the UK are for the first time to be offered for free an egg-based nasal vaccine. The intention is to prevent influenza (flu) in hopes of not just...

2014-10-14 20:23:26

CHICAGO, Oct. 14, 2014 /PRNewswire/ -- Pentamer Pharmaceuticals today announced that it has begun a crowdfunding campaign for the development of its Ebola vaccine. Dr. Stephen Hall, the Founder and CEO of Pentamer, developed a vaccine technology called NodaVax that has produced protective vaccines against other pathogens like Anthrax. Pentamer developed an Ebola vaccine (called NoBola) using this technology and has begun the crowdfunding campaign to help support vaccine...

2014-10-14 08:33:10

Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct. 14, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company, today announced that it has signed a definitive master service agreement with Pharmaceutical Product Development (PPD), a leading global contract research organization (CRO), to advance and expand clinical and regulatory development across...

2014-10-14 08:31:59

Survey of Canadian adults finds that 80 per cent believe child and adult vaccinations are of equal importance KIRKLAND, QC, Oct. 14, 2014 /CNW/ - There were more than 150 Canadian news reports about vaccine-preventable disease outbreaks between September 2013 and April 2014.(2) Amongst these reports were calls from the Public Health Agency of Canada(3 )to ensure children are vaccinated against the diseases they are most susceptible to - but what about adults? A new survey of Canadians finds...

2014-10-10 08:24:07

SAN DIEGO, Oct. 10, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. ("MabVax"), a clinical stage oncology drug development company, announced today that FINRA has approved a change in the Company's stock symbol. Effective today, the Company's common shares will commence trading on the OTC Bulletin Board under the trading symbol "MBVX" (OTCQB: MBVX.) The previous trading symbol was "TELK" (OTCQB: TELK). J. David Hansen, President and CEO of the Company, said, "We are...

2014-10-09 23:00:27

The Department of Infection Prevention and Control (IP&C) at NewYork-Presbyterian Hospital collaborated with other departments to harness information technology (IT) during a measles outbreak earlier this year – including text message alerts to vulnerable patients – to prevent the spread of the disease. New York, NY (PRWEB) October 10, 2014 Nearly 50 percent of young children returned to the hospital to receive a measles vaccination following a text message. The Department of...

2014-10-09 16:28:08

SAN DIEGO, Oct. 9, 2014 /PRNewswire/ -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value biosimilar therapeutics and difficult to manufacture proteins, today announced the initiation of a multi-product research program with PATH, a global health nonprofit organization, as part of an initiative to enhance production of vaccines. http://photos.prnewswire.com/prnvar/20140715/127348 "We are both pleased and honored to partner...

2014-10-09 16:27:38

First Study of a Promising Ebola Vaccine Undertaken in West Africa BALTIMORE, Oct. 9, 2014 /PRNewswire-USNewswire/ -- Professor Myron M. Levine, MD, Director of the Center for Vaccine Development (CVD) at the University of Maryland School of Medicine (UM SOM), and UM SOM Dean E. Albert Reece MD, Ph.D., MBA, announced today that the CVD, in conjunction with its sister institution, The Center for Vaccine Development of Mali (CVD-Mali) and the Ministry of Health of Mali, have begun a...

vaccine adjuvant
2014-10-09 08:40:25

Chuck Bednar for redOrbit.com - Your Universe Online The authors of two new studies published Wednesday in the Journal of the American Medical Association (JAMA) analyzed the use of different types of vaccines to help better prevent and control pandemic bird flu virus. In one of the studies, Saint Louis University professor of infectious diseases, allergy and immunology Dr. Robert Belshe and his colleagues found that a vaccine designed to protect against an old strain of avian flu...


Latest Vaccination Reference Libraries

0_ac8af9115d7f37daaaa2af4dba273fb1
2011-01-11 14:17:29

The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related